Mardia Samyoung Capillary Tubes Company Limited Stock Price Today (NSE: MSCTC)
Fundamental Score
Mardia Samyoung Capillary Tubes Company Limited Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Mardia Samyoung Capillary Tubes Company Limited share price today is ₹99.40, up +0.00% on NSE/BSE as of 30 March 2026. Mardia Samyoung Capillary Tubes Company Limited (MSCTC) is a Small-cap company in the Copper sector with a market capitalisation of ₹82.60 (Cr). The 52-week high for MSCTC share price is ₹123.40 and the 52-week low is ₹9.19. The company has a Return on Equity (ROE) of 24.45% and a debt-to-equity ratio of 0.00.
Mardia Samyoung Capillary Tubes Company Limited Share Price Chart — NSE/BSE Historical Performance
Returns & Performance
ROE
ROCE
OPM (5Y)
Div Yield
Mardia Samyoung Capillary Tubes Company Limited Valuation Check
P/E Ratio
Industry P/E
Market Cap
Growth Engine
Profit Growth (Q)
Sales Growth (Q)
Sales Growth (5Y)
EPS Growth (5Y)
Profit Growth (5Y)
Balance Sheet Health
Debt to Equity
Int. Coverage
Free Cash Flow (5Y)
Shareholding
Promoter
FII
DII
Pledged
Institutional Deep-Dive
Bull Run Research Hub
Mardia Samyoung Capillary Tubes Company Share Price: A Value Investor's Perspective
The copper industry, a bedrock of modern infrastructure, is currently facing a potential supply crunch due to increasing demand from renewable energy projects and electric vehicles. Understanding this backdrop is crucial when assessing companies like Mardia Samyoung Capillary Tubes Company Limited, whose products rely heavily on copper. This analysis aims to provide a conservative, value-oriented perspective on Mardia Samyoung Capillary Tubes Company share price, currently trading at ₹108.5999984741211, focusing on capital safety and long-term sustainability.
One immediate concern is the absence of a Price-to-Earnings (PE) ratio. This suggests either the company is not currently profitable or has inconsistent earnings, a significant red flag for a value investor prioritizing consistent returns and financial stability. We would need to investigate the reason behind the missing PE ratio before even considering a potential investment. Further scrutiny of financial statements to ascertain historical earnings and profitability trends is crucial.
Mardia Samyoung boasts a Return on Capital Employed (ROCE) of 22.59%. This seemingly attractive figure needs careful examination. A high ROCE indicates efficient capital allocation, potentially building a wider economic moat around the business. However, sustainability is key. We must determine if this ROCE is consistent and whether the company can maintain it in the face of fluctuating copper prices and competitive pressures. Furthermore, a high ROCE without commensurate earnings might indicate unsustainable practices or overly aggressive accounting.
While detailed management analysis is beyond the scope here, comparing Mardia Samyoung Capillary Tubes Company Limited with peers like
N D Metal Inds would shed light on relative operational efficiency and leadership quality. Ultimately, the management's vision, execution capabilities, and commitment to shareholder value are paramount to ensuring long term capital protection. For instance, comparing how both companies manage copper price volatility would allow us to discern more clearly which company has more robust cost management.This analysis is part of a more comprehensive 80-parameter fundamental audit of Mardia Samyoung Capillary Tubes Company Limited, verified by Sweta Mishra. This serves only as an observational analysis of publicly available data and should not be construed as investment advice. We are presenting findings only. There is no expression of future price movement or recommendations to buy, sell or hold.
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Mardia Samyoung Capillary Tubes Company Limited Fundamental Analysis & Valuation Benchmarking
Educational evaluation of MSCTC across key market metrics for learning purposes.
Positive Indicators
8 factors identified
Strong Return on Equity (24.45%)
Observation: Efficient use of shareholders' capital generating superior returns.
Analysis: ROE >15% indicates strong profitability and effective management. This metric suggests the company can generate substantial returns on invested capital.
Excellent ROCE Performance (22.59%)
Observation: Superior returns on capital employed across business operations.
Analysis: ROCE >15% demonstrates efficient capital deployment and strong operational performance.
Robust Profit Growth (101.40%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Excellent EPS Growth (45.65% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (45.65% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Debt-Free Balance Sheet (D/E: 0.00)
Observation: Low leverage provides financial flexibility and reduced risk.
Analysis: Conservative debt structure offers resilience during economic downturns.
Balanced Promoter Holding (69.41%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
3 factors identified
Negative Free Cash Flow (₹-0.60 Cr over 5Y)
Observation: Cash outflows exceed inflows.
Analysis: Negative FCF requires analysis of capital expenditure cycle.
Limited Institutional Interest (FII+DII: 0.08%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Mardia Samyoung Capillary Tubes Company Limited Financial Statements
Comprehensive financial data for Mardia Samyoung Capillary Tubes Company Limited including income statement, balance sheet and cash flow
About MSCTC (Mardia Samyoung Capillary Tubes Company Limited)
Mardia Samyoung Capillary Tubes Company Limited is a distinguished Indian manufacturer specializing in the production of high-precision capillary tubes, crafted primarily from prem...ium-grade copper. With decades of experience, MSCTC has established itself as a reliable source for these essential components, serving diverse industries with unwavering commitment to quality and accuracy. Their copper capillary tubes are meticulously engineered to meet exacting specifications, ensuring optimal performance in critical applications where precise fluid or gas transfer is paramount. From the initial selection of raw materials to the final inspection, every step in the manufacturing process is rigorously controlled, guaranteeing consistent quality and dimensional accuracy. MSCTC’s dedication extends beyond just production; they foster collaborative partnerships with their clients, providing technical support and customized solutions to address specific requirements. MSCTC's core strength lies in its mastery of copper processing, transforming raw material into finely calibrated capillary tubes. Copper, chosen for its superior thermal conductivity, corrosion resistance, and malleability, forms the foundation of their products. The company employs advanced drawing and annealing techniques to achieve the desired dimensions and mechanical properties. This meticulous attention to detail ensures that each capillary tube exhibits exceptional uniformity and durability, capable of withstanding demanding operating conditions. MSCTC’s commitment to innovation is evident in its continuous investment in research and development, allowing them to explore new techniques and materials to further enhance the performance of their capillary tubes. Their product range caters to a wide spectrum of applications, highlighting their ability to adapt to evolving industry needs. Located in Mumbai, India, Mardia Samyoung Capillary Tubes Company Limited operates with a customer-centric approach, focused on building long-term relationships based on trust and reliability. Their commitment to ethical business practices and environmental responsibility underscores their dedication to sustainable manufacturing. MSCTC's global outlook allows them to serve clients both domestically and internationally, delivering high-quality copper capillary tubes with timely and efficient service. The company’s unwavering pursuit of excellence, coupled with its deep understanding of copper metallurgy, positions MSCTC as a leading provider of precision capillary tubes, vital for a myriad of industrial and technological applications, ensuring seamless operation and optimal performance in diverse sectors.
Company Details
Key Leadership
MSCTC Share Price: Frequently Asked Questions
What is the current share price of Mardia Samyoung Capillary Tubes Company Limited (MSCTC)?
As of 30 Mar 2026, 12:03 pm IST, Mardia Samyoung Capillary Tubes Company Limited share price is ₹99.40. The MSCTC stock has a market capitalisation of ₹82.60 (Cr) on NSE/BSE.
Is MSCTC share price Overvalued or Undervalued?
MSCTC share price is currently trading at a P/E ratio of 0.00x, compared to the industry average of 57.19x. Based on this relative valuation, the Mardia Samyoung Capillary Tubes Company Limited stock appears to be Fairly Valued against its sector peers.
What is the 52-week high and low of MSCTC share price?
The 52-week high of MSCTC share price is ₹123.40 and the 52-week low is ₹9.19. These values are updated daily from NSE/BSE price data.
What factors affect the Mardia Samyoung Capillary Tubes Company Limited share price?
Key factors influencing MSCTC share price include quarterly earnings growth (Sales Growth: N/A%), raw material costs, government infrastructure spending, and institutional flows (FII/DII holding).
Is Mardia Samyoung Capillary Tubes Company Limited a good stock for long-term investment?
Mardia Samyoung Capillary Tubes Company Limited shows a 5-year Profit Growth of 45.65% and an ROE of 24.45%. Long-term investors should consider these fundamentals alongside the debt-to-equity ratio of 0.00 before investing in MSCTC shares.
How does Mardia Samyoung Capillary Tubes Company Limited compare with its industry peers?
Mardia Samyoung Capillary Tubes Company Limited competes with major peers in the Copper. Investors should compare MSCTC share price P/E of 0.00x and ROE of 24.45% against the industry averages to determine competitive standing.
What is the P/E ratio of MSCTC and what does it mean?
MSCTC share price has a P/E ratio of N/Ax compared to the industry average of 57.19x. Investors pay ₹N/A for every ₹1 of annual earnings.
How is MSCTC performing according to Bull Run's analysis?
MSCTC has a Bull Run fundamental score of 45/100, indicating concerns requiring careful analysis. This comprehensive rating is based on 15+ financial parameters.
What sector and industry does MSCTC belong to?
MSCTC operates in the Copper industry. This classification helps understand the competitive landscape and sector-specific trends affecting Mardia Samyoung Capillary Tubes Company Limited share price.
What is Return on Equity (ROE) and why is it important for MSCTC?
MSCTC has an ROE of 24.45%, which indicates excellent management efficiency. ROE measures how efficiently Mardia Samyoung Capillary Tubes Company Limited generates profits from shareholders capital.
How is MSCTC debt-to-equity ratio and what does it indicate?
MSCTC has a debt-to-equity ratio of 0.00, which indicates conservative financing with low financial risk.
What is MSCTC dividend yield and is it a good dividend stock?
MSCTC offers a dividend yield of 0.00%, meaning you receive ₹0.00 annual dividend for every ₹100 invested in Mardia Samyoung Capillary Tubes Company Limited shares.
How has MSCTC share price grown over the past 5 years?
MSCTC has achieved 5-year growth rates of: Sales Growth N/A%, Profit Growth 45.65%, and EPS Growth 45.65%.
What is the promoter holding in MSCTC and why does it matter?
Promoters hold 69.41% of MSCTC shares, with 0.00% pledged. High promoter holding often indicates strong management confidence in Mardia Samyoung Capillary Tubes Company Limited.
What is MSCTC market capitalisation category?
MSCTC has a market capitalisation of ₹83 crores, placing it in the Small-cap category.
How volatile is MSCTC stock?
MSCTC has a beta of N/A. A beta > 1 suggests the Mardia Samyoung Capillary Tubes Company Limited stock is more volatile than the market, while a beta < 1 suggests it is less volatile.
What is MSCTC operating profit margin trend?
MSCTC has a 5-year average Operating Profit Margin (OPM) of N/A%, indicating the company's operational efficiency.
How is MSCTC quarterly performance?
Recent quarterly performance shows Mardia Samyoung Capillary Tubes Company Limited YoY Sales Growth of N/A% and YoY Profit Growth of 101.40%.
What is the institutional holding pattern in MSCTC?
MSCTC has FII holding of 0.00% and DII holding of 0.08%. Significant institutional holding often suggests professional confidence in the Mardia Samyoung Capillary Tubes Company Limited stock.